0001225208-13-006444.txt : 20130304
0001225208-13-006444.hdr.sgml : 20130304
20130304182758
ACCESSION NUMBER: 0001225208-13-006444
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20130228
FILED AS OF DATE: 20130304
DATE AS OF CHANGE: 20130304
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Dawkins Keith D
CENTRAL INDEX KEY: 0001492253
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-11083
FILM NUMBER: 13663129
MAIL ADDRESS:
STREET 1: BOSTON SCIENTIFIC CORPORATION
STREET 2: ONE BOSTON SCIENTIFIC PLACE
CITY: NATICK
STATE: MA
ZIP: 01760
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: BOSTON SCIENTIFIC CORP
CENTRAL INDEX KEY: 0000885725
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 042695240
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: ONE BOSTON SCIENTIFIC PL
CITY: NATICK
STATE: MA
ZIP: 01760-1537
BUSINESS PHONE: 508-650-8000
MAIL ADDRESS:
STREET 1: ONE BOSTON SCIENTIFIC PL
CITY: NATICK
STATE: MA
ZIP: 01760-1537
4
1
doc4.xml
X0306
4
2013-02-28
0000885725
BOSTON SCIENTIFIC CORP
BSX
0001492253
Dawkins Keith D
ONE BOSTON SCIENTIFIC PLACE
NATICK
MA
01760-1537
1
EVP, Global Chief Med. Off.
Common Stock
2013-02-28
4
M
0
4888.0000
0.0000
A
83396.0000
D
Common Stock
2013-02-28
4
F
0
1594.0000
7.3900
D
81802.0000
D
Deferred Stock Units
2013-02-28
4
A
0
23680.0000
0.0000
A
Common Stock
23680.0000
79458.0000
D
Deferred Stock Units
2013-02-28
4
M
0
4888.0000
0.0000
D
Common Stock
4888.0000
74570.0000
D
Performance Share Units
2013-02-28
4
A
0
31050.0000
0.0000
A
2014-12-31
2014-12-31
Common Stock
31050.0000
31050.0000
D
Stock Option (Right to Buy)
7.3900
2013-02-28
4
A
0
61650.0000
0.0000
A
2023-02-28
Common Stock
61650.0000
61650.0000
D
Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock.
Shares of common stock will be issued to the reporting person in five equal annual installments beginning on February 28, 2014, the first anniversary of the date of grant.
Reflects multiple DSU awards with independent vesting schedules.
Shares of common stock will be issued to the reporting person in five equal annual installments beginning on February 28, 2012, the first anniversary of the date of grant.
Each performance share unit represents the Company's commitment to issue one share of Boston Scientific common stock.
On February 27, 2012, the reporting person was awarded a target number of performance share units under the Company's 2012 Free Cash Flow Performance Share Program, the actual number of which to be earned by the reporting person based on the Company's 2012 adjusted free cash flow measured against its 2012 financial plan over the one-year performance period ending December 31, 2012 and subject to the completion of a three-year individual service period (inclusive of the performance period). On February 28, 2013, the number of the target performance share units as to which the performance criteria had been satisfied was determined. The performance share units so determined will vest in whole on December 31, 2014 upon the completion of the individual service period.
Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 28, 2014, the first anniversary of the date of grant.
/s/ Conor Kilroy, Attorney-in-Fact
2013-03-04